Nurmukhammad, F.; Zhangelova, S.; Sugraliyev, A.; Arutyunov, A.; Kuatbayev, Y.; Mukanova, Z.; Kapsultanova, D.
Development and Preliminary Assessment of a Mortality Risk Score in Patients with Coronary Artery Disease Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. Clin. Pract. 2026, 16, 149.
https://doi.org/10.3390/clinpract16080149
AMA Style
Nurmukhammad F, Zhangelova S, Sugraliyev A, Arutyunov A, Kuatbayev Y, Mukanova Z, Kapsultanova D.
Development and Preliminary Assessment of a Mortality Risk Score in Patients with Coronary Artery Disease Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. Clinics and Practice. 2026; 16(8):149.
https://doi.org/10.3390/clinpract16080149
Chicago/Turabian Style
Nurmukhammad, Friba, Sholpan Zhangelova, Akhmetzhan Sugraliyev, Alexander Arutyunov, Yermagambet Kuatbayev, Zhanetta Mukanova, and Dina Kapsultanova.
2026. "Development and Preliminary Assessment of a Mortality Risk Score in Patients with Coronary Artery Disease Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention" Clinics and Practice 16, no. 8: 149.
https://doi.org/10.3390/clinpract16080149
APA Style
Nurmukhammad, F., Zhangelova, S., Sugraliyev, A., Arutyunov, A., Kuatbayev, Y., Mukanova, Z., & Kapsultanova, D.
(2026). Development and Preliminary Assessment of a Mortality Risk Score in Patients with Coronary Artery Disease Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. Clinics and Practice, 16(8), 149.
https://doi.org/10.3390/clinpract16080149
